Global Heart Failure Academy
Be part of the knowledge.™Global Heart Failure Academy
Leading global experts have combined guideline recommendations and new clinical data with practical, case-based formats that approximate clinical reality to improve patient outcomes in the management of heart failure. This series is focused on changing clinical behavior in the recognition and diagnoses of hyperkalemia and iron deficiency in heart failure, through the application of emerging science into everyday practice.
To return to the Global Heart Failure Academy, please click here.
This educational series is developed by Medtelligence. Supported by an unrestricted educational grant from CSL Vifor.
.png)
Episodes 1-15 of 15
- 7
CME/CE
Don’t Let Hyperkalemia Get You Down When Potassium Goes Up in Your Patients with Heart Failure
Don’t Let Hyperkalemia Get You Down When Potassium Goes Up in Your Patients with Heart Failure
- 8
CME/CE
Treating Iron Deficiency in Patients with HFrEF: A Review of the Recent Data for IV Iron Replacement Therapy
Treating Iron Deficiency in Patients with HFrEF: A Review of the Recent Data for IV Iron Replacement Therapy
- 8
CME/CE
What You Should Know When Addressing GDMT For ID in Heart Failure
What You Should Know When Addressing GDMT For ID in Heart Failure
CME/CE
What Are We Missing? Iron Deficiency in Heart Failure
What Are We Missing? Iron Deficiency in Heart Failure
CME/CE
Maximally Tolerated or Suboptimal Therapy? Clinical Perspectives on Rechallenging RAASi Therapy
Maximally Tolerated or Suboptimal Therapy? Clinical Perspectives on Rechallenging RAASi Therapy
- 25
CME/CE
Looking Beyond Diabetes: The Role of SGLT2i and MRAs in Cardiorenal Disease
Looking Beyond Diabetes: The Role of SGLT2i and MRAs in Cardiorenal Disease
CME/CE
Why Ischemia Matters When It Comes to Iron Deficiency in Heart Failure
Why Ischemia Matters When It Comes to Iron Deficiency in Heart Failure
- 16
CME/CE
The Role of Potassium Binders in Optimal HF Management: Discussing the DIAMOND Study
The Role of Potassium Binders in Optimal HF Management: Discussing the DIAMOND Study
Global Heart Failure Academy
The 4 Pillars of Treatment in HFrEF: Does Risk of Hyperkalemia Threaten to Topple Them Over?
The 4 Pillars of Treatment in HFrEF: Does Risk of Hyperkalemia Threaten to Topple Them Over?
Global Heart Failure Academy
From Paper to Patient: Applying Guideline Updates to Practice
From Paper to Patient: Applying Guideline Updates to Practice
- 8
Global Heart Failure Academy
AFFIRM-AHF: Key Takeaways
AFFIRM-AHF: Key Takeaways
- 11
Global Heart Failure Academy
Late-breaking First Response on AFFIRM-AHF
Late-breaking First Response on AFFIRM-AHF
- 8
Global Heart Failure Academy
CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy
CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy
- 2
Global Heart Failure Academy
Balancing RAASi Therapy and Potassium: Understanding How it Works
Balancing RAASi Therapy and Potassium: Understanding How it Works
- 3
Global Heart Failure Academy
Mechanisms in Heart Failure: Why Iron Deficiency Matters
Mechanisms in Heart Failure: Why Iron Deficiency Matters
